Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrophage migration inhibitory factor in uveitis.

Satoshi Kotake1, Nobuyoshi Kitaichi, Shigeaki Ohno

  • 1Department of Ophthalmology and Visual Sciences, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, Japan 060 8638.

International Ophthalmology Clinics
|August 23, 2002
PubMed
Summary

High levels of macrophage migration inhibitory factor (MIF) indicate its role in various uveitis types. MIF is crucial in active disease stages and may be a therapeutic target for uveitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pediatric Case of Blau Syndrome with <i>NOD2</i> p.Arg587Cys Mutation Successfully Managed with Infliximab: A Long-Term Follow-Up Study.

Ocular immunology and inflammation·2026
Same author

A machine learning-based fall risk prediction model for Parkinson's disease considering ophthalmic disorders.

Parkinsonism & related disorders·2026
Same author

A Case of Refractory Panuveitis with Coexisting Spondyloarthritis Successfully Treated with Tofacitinib.

Case reports in ophthalmology·2026
Same author

Clinical and OCT Predictors of Refractory Vogt-Koyanagi-Harada Disease.

Ophthalmology science·2026
Same author

The Role of Plasminogen Activator Inhibitor-1 in Uveitis: Findings from Clinical and Experimental Studies.

Current eye research·2026
Same author

Tiled-Amplicon Whole-Genome Sequencing Method Reveals Endemic Circulation of Human Adenovirus Type 3 in Japan.

Viruses·2026

Area of Science:

  • Ophthalmology
  • Immunology
  • Rheumatology

Background:

  • Uveitis is a group of inflammatory eye diseases.
  • Macrophage Migration Inhibitory Factor (MIF) is a key cytokine in immune responses.
  • The role of MIF in the pathogenesis of different uveitis subtypes requires further elucidation.

Purpose of the Study:

  • To investigate serum and aqueous humor Macrophage Migration Inhibitory Factor (MIF) levels in patients with various types of uveitis.
  • To explore the correlation between MIF levels and disease activity and treatment response.
  • To assess the therapeutic potential of anti-MIF antibodies in experimental autoimmune uveitis (EAU).

Main Methods:

  • Serum and aqueous humor samples were collected from patients with Behçet's disease, VKH disease, sarcoidosis, idiopathic iridocyclitis, and healthy controls.

Related Experiment Videos

  • Macrophage Migration Inhibitory Factor (MIF) levels were quantified using immunoassays.
  • Experimental autoimmune uveitis (EAU) was induced in animal models.
  • The effect of anti-MIF antibody treatment on EAU progression was evaluated.

    • Main Results:

    • Elevated serum MIF levels were observed in patients with active Behçet's disease, VKH disease, sarcoidosis, and idiopathic iridocyclitis compared to inactive stages or controls.
    • Serum MIF levels increased after corticosteroid therapy in VKH disease patients.
    • High MIF concentration was detected in the aqueous humor at the onset of EAU.
    • Early administration of anti-MIF antibody significantly suppressed EAU development.

    Conclusions:

    • Macrophage Migration Inhibitory Factor (MIF) is implicated in the pathogenesis of diverse uveitis conditions.
    • MIF levels correlate with disease activity and may serve as a biomarker.
    • Targeting MIF with antibodies shows therapeutic promise for uveitis.